Feasibility Evaluation of WEAR-IT for Hand Therapy After Stroke

Starting soon · Not applicable

Conditions studied: Stroke (6 Months or More After Onset)

In brief

The goal of this clinical trial is to understand whether a program of using a hand robot at home, supported by telerehabilitation, is feasible for people living with stroke. The study aims to answer the following questions: * What is the extent that people living with stroke complete the prescribed therapy program? (adherence) * Do people living with stroke continue to participate in the therapy program until follow-up? (retention) * How acceptable and helpful is the hand robot to be use at the outpatient rehabilitation clinic and home via telerehabilitation for people living with stroke? * How reliable and safe is the hand robot when used in clinical and home settings? * What are the costs of delivering the hand robot program compared to providing the same amount of standard therapy without the hand robot? Researchers will also compare rehabilitation using the hand robot program to a dose-matched therapy program that does not use the robot. * Intervention group: Participants will use the hand robot for 12 weeks, with follow-up intervention and assessments at 6 months. * Control (comparator) group: Participants will receive the same amount of therapy over 12 weeks, but without the hand robot, followed by 6-month follow-up. For both groups, researchers will record information about each participant's clinical recovery, their experience with the therapy process and the cost of care.

Key facts

Study ID: NCT07698067
Run by: Dr. Rosalie Wang
People needed: 44
Starts: 2026-09-01
Expected to finish: 2029-12-23
Last updated by the study team: 2026-07-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Each participant must meet all of the following inclusion criteria to participate in this study:
A) Persons with chronic stroke:
Be able to attend one rehabilitation site (Toronto or Edmonton),
Be 18 years of age or older,
Be able to provide informed consent,
Has English language proficiency,
Be in the chronic stage of recovery (e.g., > 6 months post-stroke),
Have hand recovery at Stage 1 (flaccid paralysis) to Stage 4 (inability to make a fist and then extend the fingers fully) on the Chedoke-McMaster Stroke Assessment (CMSA)
Have a pain rating between 0/10 (no pain) and 4/10 (moderate pain) at rest and with assisted hand movement
Demonstrate the ability to understand and participate in a 3-month study program,
Live with someone or have someone consistently available (caregiver participant) who can help with setting up telerehabilitation equipment and assist with putting on/removing the Glove (as needed), and
Have access to a computer or tablet with a camera and a reliable internet connection for telerehabilitation sessions.
B) Caregiver participants who are willing to assist people living with stroke can be included if they meet the following criteria:
Be 18 years of age or older,
Be able to provide informed consent , and
Be able to support glove donning/doffing, set-up, and therapy for people living with stroke at home.

You may not qualify if…

All participants meeting any of the following exclusion criteria at baseline will be excluded from participation in this study:
A) Persons with chronic stroke:
Have no limitations in fully extending fingers or making a fist,
Are experiencing pain or cognitive impairments that prevent active participation in therapy,
Be unable to communicate with therapists independently,
Have had any musculoskeletal or other neurological conditions that would impact their participation in a hand rehabilitation program, or
Are currently involved in another rehabilitation program aimed at improving upper limb movement.

Where it is running

Glenrose Rehabilitation Hospital — Edmonton, Alberta, Canada
Sunnybrook - St. John's Rehab — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.